Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

The influence of body mass index on temperature management during general anaesthesia-A prospective observational study.

Groene P, Zeuzem C, Baasner S, Hofmann-Kiefer K.

J Eval Clin Pract. 2019 Apr;25(2):340-345. doi: 10.1111/jep.13064. Epub 2018 Nov 18.

PMID:
30450648
2.

Clinical significance and risk factors for new onset and recurring atrial fibrillation following cardiac surgery - a retrospective data analysis.

Todorov H, Janssen I, Honndorf S, Bause D, Gottschalk A, Baasner S, Volkert T, Faerber V, Stover JF, Westphal M, Ellger B.

BMC Anesthesiol. 2017 Dec 2;17(1):163. doi: 10.1186/s12871-017-0455-7.

3.

Fully Balanced Fluids do not Improve Microvascular Oxygenation, Acidosis and Renal Function in a Rat Model of Endotoxemia.

Ergin B, Zafrani L, Kandil A, Baasner S, Lupp C, Demirci C, Westphal M, Ince C.

Shock. 2016 Jul;46(1):83-91. doi: 10.1097/SHK.0000000000000573.

PMID:
26825634
4.

Differentiated control of deranged nitric oxide metabolism: a therapeutic option in sepsis?

Lupp C, Baasner S, Ince C, Nocken F, Stover JF, Westphal M.

Crit Care. 2013 May 29;17(3):311. doi: 10.1186/cc12538. Review.

5.

Phenylimino-10H-anthracen-9-ones as novel antimicrotubule agents-synthesis, antiproliferative activity and inhibition of tubulin polymerization.

Prinz H, Schmidt P, Böhm KJ, Baasner S, Müller K, Gerlach M, Günther EG, Unger E.

Bioorg Med Chem. 2011 Jul 15;19(14):4183-91. doi: 10.1016/j.bmc.2011.06.010. Epub 2011 Jun 12.

PMID:
21705223
6.

Synthesis, antiproliferative activity and inhibition of tubulin polymerization by 1,5- and 1,8-disubstituted 10H-anthracen-9-ones bearing a 10-benzylidene or 10-(2-oxo-2-phenylethylidene) moiety.

Nickel HC, Schmidt P, Böhm KJ, Baasner S, Müller K, Gerlach M, Unger E, Günther EG, Prinz H.

Eur J Med Chem. 2010 Aug;45(8):3420-38. doi: 10.1016/j.ejmech.2010.04.032.

PMID:
20537765
7.

Synthesis and structure-activity relationships of N-aryl(indol-3-yl)glyoxamides as antitumor agents.

Marchand P, Antoine M, Le Baut G, Czech M, Baasner S, Günther E.

Bioorg Med Chem. 2009 Sep 15;17(18):6715-27. doi: 10.1016/j.bmc.2009.07.048. Epub 2009 Jul 25.

PMID:
19682911
8.

Development of AEZS-115 (ZEN-019) by optimization of structurally unique, orally active, peptidomimetic GnRH antagonists.

Paulini KW, Baasner S, Gerlach M, Polymeropoulos EE, Schmidt P, Schuster T, Teifel M, Guenther EG.

Adv Exp Med Biol. 2009;611:521-2. No abstract available.

PMID:
19400294
9.

10-(2-oxo-2-phenylethylidene)-10H-anthracen-9-ones as highly active antimicrotubule agents: synthesis, antiproliferative activity, and inhibition of tubulin polymerization.

Prinz H, Schmidt P, Böhm KJ, Baasner S, Müller K, Unger E, Gerlach M, Günther EG.

J Med Chem. 2009 Mar 12;52(5):1284-94. doi: 10.1021/jm801338r.

PMID:
19220018
10.

Side chain modifications of (indol-3-yl)glyoxamides as antitumor agents.

Antoine M, Marchand P, Le Baut G, Czech M, Baasner S, Gunther E.

J Enzyme Inhib Med Chem. 2008 Oct;23(5):686-95. doi: 10.1080/14756360802207998 .

PMID:
18821257
11.

Sulfonate derivatives of naphtho[2,3-b]thiophen-4(9H)-one and 9(10H)-anthracenone as highly active antimicrotubule agents. Synthesis, antiproliferative activity, and inhibition of tubulin polymerization.

Zuse A, Schmidt P, Baasner S, Böhm KJ, Müller K, Gerlach M, Günther EG, Unger E, Prinz H.

J Med Chem. 2007 Nov 29;50(24):6059-66. Epub 2007 Oct 31.

PMID:
17973361
12.

9-Benzylidene-naphtho[2,3-b]thiophen-4-ones as novel antimicrotubule agents-synthesis, antiproliferative activity, and inhibition of tubulin polymerization.

Zuse A, Schmidt P, Baasner S, Böhm KJ, Müller K, Gerlach M, Günther EG, Unger E, Prinz H.

J Med Chem. 2006 Dec 28;49(26):7816-25.

PMID:
17181164
13.

Design and synthesis of a focused library of novel aryl- and heteroaryl-ketopiperazides.

Gerlach M, Claus E, Baasner S, Müller G, Polymeropoulos E, Schmidt P, Günther E, Engel J.

Arch Pharm (Weinheim). 2004 Dec;337(12):695-703.

PMID:
15597403
14.

Switching off HER-2/neu in a tetracycline-controlled mouse tumor model leads to apoptosis and tumor-size-dependent remission.

Schiffer IB, Gebhard S, Heimerdinger CK, Heling A, Hast J, Wollscheid U, Seliger B, Tanner B, Gilbert S, Beckers T, Baasner S, Brenner W, Spangenberg C, Prawitt D, Trost T, Schreiber WG, Zabel B, Thelen M, Lehr HA, Oesch F, Hengstler JG.

Cancer Res. 2003 Nov 1;63(21):7221-31.

15.

Bis(1H-2-indolyl)methanones as a novel class of inhibitors of the platelet-derived growth factor receptor kinase.

Mahboobi S, Teller S, Pongratz H, Hufsky H, Sellmer A, Botzki A, Uecker A, Beckers T, Baasner S, Schächtele C, Uberall F, Kassack MU, Dove S, Böhmer FD.

J Med Chem. 2002 Feb 28;45(5):1002-18.

PMID:
11855980
16.

Synthetic 2-aroylindole derivatives as a new class of potent tubulin-inhibitory, antimitotic agents.

Mahboobi S, Pongratz H, Hufsky H, Hockemeyer J, Frieser M, Lyssenko A, Paper DH, Bürgermeister J, Böhmer FD, Fiebig HH, Burger AM, Baasner S, Beckers T.

J Med Chem. 2001 Dec 20;44(26):4535-53.

PMID:
11741473
17.

Pyrrolo[3,4-c]-beta-carboline-diones as a novel class of inhibitors of the platelet-derived growth factor receptor kinase.

Teller S, Eluwa S, Koller M, Uecker A, Beckers T, Baasner S, Böhmer FD, Mahboobi S.

Eur J Med Chem. 2000 Apr;35(4):413-27.

PMID:
10858602
18.

Reversible tumorigenesis in mice by conditional expression of the HER2/c-erbB2 receptor tyrosine kinase.

Baasner S, von Melchner H, Klenner T, Hilgard P, Beckers T.

Oncogene. 1996 Sep 5;13(5):901-11.

PMID:
8806679

Supplemental Content

Loading ...
Support Center